Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7

Background The dietary agent sulforaphane (SFN) has been reported to reduce diabetes-induced renal fibrosis, as well as inhibit histone deacetylase (HDAC) activity. Bone morphologic protein 7 (BMP-7) has been shown to reduce renal fibrosis induced by transforming growth factor-beta1. The aim of this...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lili Kong, Hongyue Wang, Chenhao Li, Huiyan Cheng, Yan Cui, Li Liu, Ying Zhao
Formato: article
Lenguaje:EN
Publicado: Korean Diabetes Association 2021
Materias:
Acceso en línea:https://doaj.org/article/aa71d2dc0dc64f388810ccd4f18dfbc4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:aa71d2dc0dc64f388810ccd4f18dfbc4
record_format dspace
spelling oai:doaj.org-article:aa71d2dc0dc64f388810ccd4f18dfbc42021-12-01T05:07:51ZSulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-72233-60792233-608710.4093/dmj.2020.0168https://doaj.org/article/aa71d2dc0dc64f388810ccd4f18dfbc42021-11-01T00:00:00Zhttp://www.e-dmj.org/upload/pdf/dmj-2020-0168.pdfhttps://doaj.org/toc/2233-6079https://doaj.org/toc/2233-6087Background The dietary agent sulforaphane (SFN) has been reported to reduce diabetes-induced renal fibrosis, as well as inhibit histone deacetylase (HDAC) activity. Bone morphologic protein 7 (BMP-7) has been shown to reduce renal fibrosis induced by transforming growth factor-beta1. The aim of this study was to investigate the epigenetic effect of SFN on BMP-7 expression in diabetes-induced renal fibrosis. Methods Streptozotocin (STZ)-induced diabetic mice and age-matched controls were subcutaneously injected with SFN or vehicle for 4 months to measure the in vivo effects of SFN on the kidneys. The human renal proximal tubular (HK11) cell line was used to mimic diabetic conditions in vitro. HK11 cells were transfected to over-express HDAC2 and treated with high glucose/palmitate (HG/Pal) to explore the epigenetic modulation of BMP-7 in SFN-mediated protection against HG/Pal-induced renal fibrosis. Results SFN significantly attenuated diabetes-induced renal fibrosis in vivo. Among all of the HDACs we detected, HDAC2 activity was markedly elevated in the STZ-induced diabetic kidneys and HG/Pal-treated HK11 cells. SFN inhibited the diabetes-induced increase in HDAC2 activity which was associated with histone acetylation and transcriptional activation of the BMP-7 promoter. HDAC2 over-expression reduced BMP-7 expression and abolished the SFN-mediated protection against HG/Pal-induced fibrosis in vitro. Conclusion Our study demonstrates that the HDAC inhibitor SFN protects against diabetes-induced renal fibrosis through epigenetic up-regulation of BMP-7.Lili KongHongyue WangChenhao LiHuiyan ChengYan CuiLi LiuYing ZhaoKorean Diabetes Associationarticlebone morphogenetic protein 7diabetic nephropathieshistone deacetylase 2sulforafanDiseases of the endocrine glands. Clinical endocrinologyRC648-665ENDiabetes & Metabolism Journal, Vol 45, Iss 6, Pp 909-920 (2021)
institution DOAJ
collection DOAJ
language EN
topic bone morphogenetic protein 7
diabetic nephropathies
histone deacetylase 2
sulforafan
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
spellingShingle bone morphogenetic protein 7
diabetic nephropathies
histone deacetylase 2
sulforafan
Diseases of the endocrine glands. Clinical endocrinology
RC648-665
Lili Kong
Hongyue Wang
Chenhao Li
Huiyan Cheng
Yan Cui
Li Liu
Ying Zhao
Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7
description Background The dietary agent sulforaphane (SFN) has been reported to reduce diabetes-induced renal fibrosis, as well as inhibit histone deacetylase (HDAC) activity. Bone morphologic protein 7 (BMP-7) has been shown to reduce renal fibrosis induced by transforming growth factor-beta1. The aim of this study was to investigate the epigenetic effect of SFN on BMP-7 expression in diabetes-induced renal fibrosis. Methods Streptozotocin (STZ)-induced diabetic mice and age-matched controls were subcutaneously injected with SFN or vehicle for 4 months to measure the in vivo effects of SFN on the kidneys. The human renal proximal tubular (HK11) cell line was used to mimic diabetic conditions in vitro. HK11 cells were transfected to over-express HDAC2 and treated with high glucose/palmitate (HG/Pal) to explore the epigenetic modulation of BMP-7 in SFN-mediated protection against HG/Pal-induced renal fibrosis. Results SFN significantly attenuated diabetes-induced renal fibrosis in vivo. Among all of the HDACs we detected, HDAC2 activity was markedly elevated in the STZ-induced diabetic kidneys and HG/Pal-treated HK11 cells. SFN inhibited the diabetes-induced increase in HDAC2 activity which was associated with histone acetylation and transcriptional activation of the BMP-7 promoter. HDAC2 over-expression reduced BMP-7 expression and abolished the SFN-mediated protection against HG/Pal-induced fibrosis in vitro. Conclusion Our study demonstrates that the HDAC inhibitor SFN protects against diabetes-induced renal fibrosis through epigenetic up-regulation of BMP-7.
format article
author Lili Kong
Hongyue Wang
Chenhao Li
Huiyan Cheng
Yan Cui
Li Liu
Ying Zhao
author_facet Lili Kong
Hongyue Wang
Chenhao Li
Huiyan Cheng
Yan Cui
Li Liu
Ying Zhao
author_sort Lili Kong
title Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7
title_short Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7
title_full Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7
title_fullStr Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7
title_full_unstemmed Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7
title_sort sulforaphane ameliorates diabetes-induced renal fibrosis through epigenetic up-regulation of bmp-7
publisher Korean Diabetes Association
publishDate 2021
url https://doaj.org/article/aa71d2dc0dc64f388810ccd4f18dfbc4
work_keys_str_mv AT lilikong sulforaphaneamelioratesdiabetesinducedrenalfibrosisthroughepigeneticupregulationofbmp7
AT hongyuewang sulforaphaneamelioratesdiabetesinducedrenalfibrosisthroughepigeneticupregulationofbmp7
AT chenhaoli sulforaphaneamelioratesdiabetesinducedrenalfibrosisthroughepigeneticupregulationofbmp7
AT huiyancheng sulforaphaneamelioratesdiabetesinducedrenalfibrosisthroughepigeneticupregulationofbmp7
AT yancui sulforaphaneamelioratesdiabetesinducedrenalfibrosisthroughepigeneticupregulationofbmp7
AT liliu sulforaphaneamelioratesdiabetesinducedrenalfibrosisthroughepigeneticupregulationofbmp7
AT yingzhao sulforaphaneamelioratesdiabetesinducedrenalfibrosisthroughepigeneticupregulationofbmp7
_version_ 1718405563801403392